Mounjaro, Wegovy and Ozempic belong to a class of drugs called GLP-1 analogues. Mounjaro has both GLP-1 and GIP. 

These medications regulate blood sugar and appetite by slowing down the gastric emptying, increasing insulin sensitivity and suppressing glucagon production. As the medication suppresses appetite, it can make maintaining a calorie deficit feel easier for many people. 

Unlike traditional dieting, where hunger eventually drives people to break their calorie deficit, Mounjaro, Wegovy, and Ozempic-like medications can sustain appetite suppression for months or even years, potentially leading to prolonged periods of significant calorie restrictions. 

But why can a prolonged and very-low-calorie deficit be of concern?

Read the full article here to learn more: https://www.thelondonobesityclinic.com/low-calorie-diet-whilst-on-glp-1/